Completed PHASE2 INTERVENTIONAL 4-arm NCT02515864

Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

A Crossover Study to Assess the Effects of FYU-981 on the QT/QTc Interval in Healthy Male and Female Volunteers

Sponsor: Fuji Yakuhin Co., Ltd.

Conditions Healthy

Interventions FYU-981 Moxifloxacin Moxifloxacin Placebo Placebo

Updated 7 times since 2017 Last updated: Sep 7, 2017 Started: Aug 31, 2015 Primary completion: Mar 31, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Healthy, this trial is completed. The trial is conducted by Fuji Yakuhin Co., Ltd. and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Oct 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Feb 2017 — Oct 2017 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fuji Yakuhin Co., Ltd.

Data source: Fuji Yakuhin Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Japan, Japan